N. Grinshtein

发表

System-Level Analysis of Neuroblastoma Tumor–Initiating Cells Implicates AURKB as a Novel Drug Target for Neuroblastoma

M. Moran, J. Moffat, M. Marra, 2010, Clinical Cancer Research.

Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma.

J. Moffat, K. Brown, J. Nilvebrant, 2018, Cancer research.

Glioma-derived IL-33 orchestrates an inflammatory brain tumor microenvironment that accelerates glioma progression

Steven J. M. Jones, Karlyne M. Reilly, M. Marra, 2020, Nature Communications.

Combining Cancer Vaccines with Conventional Therapies

J. Bramson, N. Grinshtein, Natalie Grinshtein, 2011 .

The CD8+ T Cell Population Elicited by Recombinant Adenovirus Displays a Novel Partially Exhausted Phenotype Associated with Prolonged Antigen Presentation That Nonetheless Provides Long-Term Immunity1

J. Bramson, N. Grinshtein, Y. Wan, 2006, The Journal of Immunology.

Long-Term Immunity with Prolonged Antigen Presentation That Partially Exhausted Phenotype Associated Recombinant Adenovirus Displays a Novel T Cell Population Elicited by + The CD 8

J. Bramson, N. Grinshtein, Y. Wan, 2005 .

Persistence of Transgene Expression Influences CD8+ T-Cell Expansion and Maintenance following Immunization with Recombinant Adenovirus

R. Parks, J. Bramson, N. Grinshtein, 2009, Journal of Virology.

High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome

J. Bramson, F. Beermann, N. Grinshtein, 2009, Cancer Gene Therapy.

Recombinant adenovirus vaccines can successfully elicit CD8+ T cell immunity under conditions of extreme leukopenia.

G. Denisova, J. Bramson, N. Grinshtein, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

tem-Level Analysis of Neuroblastoma Tumor–Initiating ls Implicates AURKB as a Novel Drug Target

Hirst, Paul J. Taylor, J. Moffat, 2010 .

Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells.

J. Wrana, A. Datti, D. Kaplan, 2011, Cancer research.

T-cell immunity generated by recombinant adenovirus vaccines

J. Bramson, N. Grinshtein, J. Finn, 2007, Expert review of vaccines.

The magnitude of the CD8+ T cell response produced by recombinant virus vectors is a function of both the antigen and the vector.

J. Bramson, N. Grinshtein, Y. Wan, 2007, Cellular immunology.

Neoadjuvant vaccination provides superior protection against tumor relapse following surgery compared with adjuvant vaccination.

J. Bramson, N. Grinshtein, B. Bridle, 2009, Cancer research.

JCB_201705085 3655..3676

M. Moran, L. Rubin, J. Krieger, 2017 .

Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma

S. Weiss, J. Cairncross, J. Wrana, 2016, Clinical Cancer Research.

Therapeutics, Targets, Chemical Biology Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells

J. Wrana, A. Datti, D. Kaplan, 2011 .

Therapeutics , Targets , and Chemical Biology Small Molecule Kinase Inhibitor Screen Identifies Polo-Like Kinase 1 as a Target for Neuroblastoma Tumor-Initiating Cells

J. Wrana, A. Datti, D. Kaplan, 2011 .

Helper-dependent adenoviral vectors containing modified fiber for improved transduction of developing and mature muscle cells.

R. Parks, B. Jasmin, J. Bramson, 2004, Human gene therapy.

A neuroprotective agent that inactivates prodegenerative TrkA and preserves mitochondria

M. Moran, L. Rubin, J. Krieger, 2017, The Journal of cell biology.

Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells

Steven J. M. Jones, M. Marra, Jake Lever, 2016, Oncotarget.

Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments

Steven J. M. Jones, Richard A. Moore, S. Weiss, 2019, Proceedings of the National Academy of Sciences.

EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY

Tina N. Davis, Forrest M Kievit, Atique U. Ahmed, 2013 .

CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells.

J. Boudreau, Liang Zhang, S. Swift, 2011, Blood.

T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells

J. Boudreau, Liang Zhang, S. Swift, 2011 .

Selective targeting of neuroblastoma tumour-initiating cells by compounds identified in stem cell-based small molecule screens

J. Moffat, M. Marra, O. Morozova, 2010, EMBO molecular medicine.

Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma.

Kagan Kerman, David R Kaplan, Samuel Weiss, 2013, ACS medicinal chemistry letters.

On the role of CD4+ T cells in the CD8+ T-cell response elicited by recombinant adenovirus vaccines.

Yonghong Wan, J. Bramson, Wenzhong Zhou, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Mechanism of low-density lipoprotein oxidation by hemoglobin-derived iron.

V. Bamm, N. Grinshtein, V. Tsemakhovich, 2003, Biochemistry.

Elevated frequencies of self-reactive CD8+ T cells following immunization with a xenoantigen are due to the presence of a heteroclitic CD4+ T-cell helper epitope.

J. Bramson, F. Beermann, N. Grinshtein, 2007, Cancer research.

IGF-1R Targeted Alpha Therapeutic FPI-1434 causes DNA Double-stranded Breaks and Induces Regression in Preclinical Models of Human Cancer

J. Valliant, N. Grinshtein, Meiduo Hu, 2019, Journal of Medical Imaging and Radiation Sciences.